Dehydration

Back

Background

Dehydration describes a state of negative fluid balance that may be caused by numerous disease entities. Diarrheal illnesses are the most common etiologies. Worldwide, dehydration secondary to diarrheal illness is the leading cause of infant and child mortality.

For patient education materials, see Children's Health Center as well as Dehydration in Children.

Pathophysiology

The negative fluid balance that causes dehydration results from decreased intake, increased output (renal, gastrointestinal [GI], or insensible losses), or fluid shift (ascites, effusions, and capillary leak states such as burns and sepsis). The decrease in total body water causes reductions in both the intracellular and extracellular fluid volumes. Clinical manifestations of dehydration are most closely related to intravascular volume depletion and the physiologic compensation attempts that takes place. As dehydration progresses, hypovolemic shock ultimately ensues, resulting in end organ failure and death.

Young children are more susceptible to dehydration due to larger body water content, renal immaturity, and inability to meet their own needs independently. Older children show signs of dehydration sooner than infants due to lower levels of extracellular fluid (ECF).

Dehydration can be categorized according to osmolarity and severity. Serum sodium is a good surrogate marker of osmolarity assuming the patient has a normal serum glucose. (Osmolarity = [2 × sodium] + [glucose/18] + [blood urea nitrogen/2.8]) Dehydration may be isonatremic (130-150 mEq/L), hyponatremic (< 130 mEq/L), or hypernatremic (>150 mEq/L). Isonatremic dehydration is the most common (80%). Hypernatremic and hyponatremic dehydration each comprise 5-10% of cases. Variations in serum sodium reflect the composition of the fluids lost and have different pathophysiologic effects, as follows:

Neurologic complications can occur in hyponatremic and hypernatremic states. Severe hyponatremia may lead to intractable seizures, whereas rapid correction of chronic hyponatremia (>2 mEq/L/h) has been associated with central pontine myelinolysis. During hypernatremic dehydration, water is osmotically pulled from cells into the extracellular space. To compensate, cells can generate osmotically active particles (idiogenic osmoles) that pull water back into the cell and maintain cellular fluid volume. During rapid rehydration of hypernatremia, the increased osmotic activity of these cells can result in a large influx of water, causing cellular swelling and rupture; cerebral edema is the most devastating consequence. Slow rehydration over 48 hours generally minimizes this risk (not to exceed 0.5 mEq/L per hour; 10-12 mEq/L in 24 hours).

Etiology

Determination of the cause of dehydration is essential. Poor fluid intake, excessive fluid output, increased insensible fluid losses, or a combination of the above may cause intravascular volume depletion. Successful treatment requires identification of the underlying disease state.

Common causes of dehydration include the following:

Life-threatening causes of dehydration include the following:

Epidemiology

United States data

Diarrheal illnesses in children causes 3 million physician visits, 220,000 hospitalizations (10% of all children who require hospitalization), and 400 deaths per year. Children younger than 5 years are at the highest risk. On average, North American children younger than 5 years have 2 episodes of gastroenteritis per year.

International data

Diarrheal illnesses with subsequent dehydration account for nearly 4 million deaths per year in infants and children. The overwhelming majority of these deaths occur in developing nations.

Prognosis

The prognosis is excellent if the child is promptly and effectively treated. However, the child with severe dehydration and hypovolemic shock can have significant morbidity and mortality if treatment is delayed.

Mortality/morbidity

Mortality and morbidity generally depend on the severity of dehydration and the promptness of oral or intravenous rehydration. If treatment is rapidly and appropriately obtained, morbidity and mortality are low.

Complications may include irreversible shock, sagittal or other venous sinus thrombosis, intractable seizures, and renal failure.

History

The following should be considered in patients with dehydration:

Physical Examination

A complete physical examination may assist in determining the underlying cause of the patient's dehydration and in defining the severity of dehydration. The clinical assessment of severity of dehydration determines the approach to management. Rather than attempting to assign an exact percentage of dehydration, one should attempt to place the child in one of 3 broad categories.

The determination of dehydration severity should be based on the overall constellation of symptoms. Patients in a given category need not exhibit all the signs and symptoms listed below. Literature reviews have suggested that delayed capillary refill, delayed skin turgor, and abnormal respiratory pattern are the most reliable clinical signs of dehydration in children. Validated clinical dehydration scales may be a useful adjunct to predict need for intravenous fluid and longer stays in the emergency department.[9]

A prospective pilot cohort study of 242 Italian children at two emergency departments found that capillary refilling time was a useful and quick triage parameter for identifying pediatric dehydration requiring prompt rehydration.[10]

Table 1. Clinical Findings of Dehydration



View Table

See Table

Table 2. Estimated Fluid Deficit



View Table

See Table

Laboratory Studies

No definitive laboratory test for dehydration is available. Laboratory data are generally not required if the etiology is apparent and mild-to-moderate dehydration is present.

With severe dehydration, the following laboratory studies are suggested:

Procedures

Intravenous line

If severe dehydration is present, peripheral intravenous line insertion may be difficult. The preferred sites for initial insertion attempts include the basilic and cephalic veins in the antecubital fossa and the saphenous veins near the ankle. Transillumination of the insertion site with a fiberoptic light source may be used to facilitate locating the desired vein.

If peripheral intravenous access cannot be rapidly achieved (< 90 s) in a child with severe dehydration and shock, intraosseous cannulation should be attempted. If the child is not in extremis, more time may be taken to establish central venous access percutaneously (eg, femoral, subclavian, internal, external jugular).

Intraosseous line

Intraosseous cannulation can be easily and rapidly achieved in children younger than 6 years. Specially designed intraosseous infusion needles or Jamshidi-type bone marrow aspiration needles may be used. Short large-bore spinal needles may also be used but often bend during placement. The ideal site of insertion is the anteromedial surface of the tibia, 1-3 cm below the anterior tibial tuberosity. Care must be taken to avoid injury to the physeal growth plate.

Orogastric/nasogastric tube

An orogastric/nasogastric tube may be inserted to facilitate enteral rehydration in children with mild-to-moderate dehydration. These tubes should be considered to assist in the nutritional recovery of children who are critically ill or severely dehydrated.

Medical Care

Hydration and nutrition are the interventions with the greatest impact on the course of acute diarrhea.[13, 14] The use of clinical dehydration scales/scores for the evaluation of the severity of dehydration and early initiation of rehydration may positively impact outcomes.[14, 15]

Medications such as loperamide, opiates, anticholinergics, bismuth subsalicylate, and adsorbents are not recommended in dehydration because of questionable efficacy and potential adverse effects.

Severe dehydration warrants hospital admission for rehydration with isotonic saline, as do hypernatremic or hyponatremic states.[13]

Inability to tolerate oral rehydration therapy (ORT) may necessitate hospital admission for nasogastric or intravenous fluid therapy.

Oral rehydration solutions

During gastroenteritis, the intestinal mucosa retains absorptive capacity. Sodium and glucose in the correct proportions can be passively cotransported with fluid from the gut lumen into the circulation. Rapid oral rehydration with the appropriate solution has been shown to be as effective as intravenous fluid therapy in restoring intravascular volume and correcting acidosis.

Table 3. Composition of Appropriate Oral Rehydration Solutions



View Table

See Table

The World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) have a standard and reduced osmolarity formulation of their oral rehydration solution.

Table 4. WHO-UNICEF Oral Rehydration Solutions



View Table

See Table

All of the commercially available rehydration fluids are acceptable for oral rehydration therapy (ORT). They contain 2-3 g/dL of glucose, 45-90 mEq/L of sodium, 30 mEq/L of base, and 20-25 mEq/L of potassium. Osmolality is 200-310 mOsm/L.

In children with severe acute malnutrition and diarrhea, low osmolarity oral rehydration solution (ORS) (osmolarity: 245, sodium: 75 mEq/L) with added potassium (20 mmol/L) appears to be equally effective for successful rehydration as modified World Health Organization–recommended rehydration solution (ReSoMal) (osmolarity: 300, sodium: 45 mEq/L) but achieves rehydration more quickly.[18] Both solutions also correct for hypokalemia, but hyponatremia may affect fewer children with the low-osmolarity ORS formulation. These findings indicate that the low osmolarity ORS may be an option in regions where ReSoMal is not available (eg, India).[18]

Table 5. Composition of Inappropriate Oral Rehydration Solutions



View Table

See Table

Traditional clear fluids are not appropriate for ORT. Many contain excessive concentrations of CHO and low concentrations of sodium. The inappropriate glucose-to-sodium ratio impairs water absorption, and the large osmotic load creates an osmotic diarrhea, further worsening the degree of dehydration.

ORT for mild or moderate dehydration

Mild or moderate dehydration can usually be treated very effectively with ORT.[19]

Vomiting is generally not a contraindication to ORT. If evidence of bowel obstruction, ileus, or acute abdomen is noted, then intravenous rehydration is indicated.

Calculate the fluid deficit. Physical findings consistent with mild dehydration suggest a fluid deficit of 5% of body weight in infants and 3% in children. Moderate dehydration occurs with a fluid deficit of 5-10% in infants and 3-6% in children (see Table 1 and Table 2). The fluid deficit should be replaced over 4 hours. Documented recent change in weight remains the standard for calculating fluid deficit if the values are available. (This is especially helpful with infants since they have relatively frequent well childcare visits that include weight checks.)

The oral rehydration solution should be administered in small volumes very frequently to minimize gastric distention and reflex vomiting. Generally, 5 mL of oral rehydration solution every minute is well tolerated. Hourly intake and output should be recorded by the caregiver. As the child becomes rehydrated, vomiting often decreases and larger fluid volumes may be used.

If vomiting persists, infusion of oral rehydration solution via a nasogastric tube may be temporarily used to achieve rehydration. Intravenous fluid administration (20-30 mL/kg of isotonic sodium chloride 0.9% solution over 1-2 h) may also be used until oral rehydration is tolerated. According to a Cochrane systematic review, for every 25 children treated with ORT for dehydration, one fails and requires intravenous therapy.[20]

Replace ongoing losses from stools and emesis (estimate volume and replace) in addition to replacing the calculated fluid deficit.

An age appropriate diet may be started as soon as the child is able to tolerate oral intake.

Severe dehydration

Laboratory evaluation and intravenous rehydration are required. The underlying cause of the dehydration must be determined and appropriately treated.

Phase 1 focuses on emergency management, the restoration of hemodynamic integrity. Severe dehydration is characterized by a state of hypovolemic shock requiring rapid treatment. Initial management includes placement of an intravenous or intraosseous line and rapid administration of 20 mL/kg of an isotonic crystalloid (eg, lactated Ringer solution, 0.9% sodium chloride). Additional fluid boluses may be required depending on the severity of the dehydration. The child should be frequently reassessed to determine the response to treatment. As intravascular volume is replenished, tachycardia, capillary refill, urine output, and mental status all should improve. If improvement is not observed after 60 mL/kg of fluid administration, other etiologies of shock (eg, cardiac [may be more apparent following the initial fluid bolus before reaching 60 mL/kg – evidence of a gallop on examination, rales], anaphylactic, septic) should be considered. Hemodynamic monitoring and inotropic support may be indicated.

Phase 2 focuses on unaddressed deficit replacement after phase 1, provision of maintenance fluids, and replacement of ongoing losses. Maintenance fluid requirements are equal to measured fluid losses (urine, stool) plus insensible fluid losses. Normal insensible fluid loss is approximately 400-500 mL/m2 body surface area and may be increased by factors such as fever and tachypnea.

Alternatively, daily maintenance (not including pathologic ongoing loss) fluid requirements may be roughly estimated as follows:

Severe dehydration by clinical examination suggests a fluid deficit of 10-15% of body weight in infants and 6-9% of body weight in older children. The daily maintenance fluid is added to the fluid deficit. In general, the recommended administration is one half of this volume administered over 8 hours and administration of the remainder over the following 16 hours. Continued losses (eg, emesis, diarrhea) must be promptly replaced.

If the child is isonatremic (130-150 mEq/L), the sodium deficit incurred can generally be corrected by administering the remaining fluid deficit after phase 1 plus maintenance as 5% dextrose in 0.45-0.9% sodium chloride. Potassium (20 mEq/L potassium chloride) may be added to maintenance fluid once urine output is established and serum potassium levels are within a safe range.

An alternative approach to the deficit therapy approach is rapid replacement therapy. With this approach, a child with severe isonatremic dehydration is administered 20-40 mL/kg of isotonic sodium chloride solution or lactated Ringer solution over 15-60 minutes. As perfusion is restored, the child improves and is able to tolerate an oral rehydration solution for the remainder of his rehydration. This approach is not appropriate for hypernatremic or hyponatremic dehydration.

Hyponatremic dehydration

Phase 1 management of hyponatremic dehydration is identical to that of isonatremic dehydration. Rapid volume expansion with 20 mL/kg of isotonic (0.9%) sodium chloride solution or lactated Ringer solution should be administered and repeated until perfusion is restored.

Severe hyponatremia (< 130 mEq/L) indicates additional sodium loss in excess of water loss. In phase 2 management, rehydration is calculated as for isonatremic dehydration. The additional sodium deficit must be calculated and added to the rehydration fluids. The deficit may be calculated to restore the sodium to 130 mEq/L and administered over 48 hours, as follows:

A simplified approach is to use 5% dextrose in 0.9% sodium chloride as the replacement fluid. The sodium is closely monitored, and the amount of sodium in the fluid is adjusted to maintain a slow correction (about < 0.5 mEq/L/h, with a correction goal of 8 mEq/L over 24 hours).

Frequently reassessing the serum sodium level during correction is imperative. Rapid correction of chronic hyponatremia (>2 mEq/L/h) has been associated with central pontine myelinolysis. Rapid partial correction of symptomatic hyponatremia has not been associated with adverse effects. Therefore, if the child is symptomatic (seizures), a more rapid partial correction is indicated. Hypertonic (3%) sodium chloride solution (0.5 mEq/mL) may be used for rapid partial correction of symptomatic hyponatremia. A bolus dose of 4 mL/kg raises the serum sodium by 3-4 mEq/L.

Hypernatremic dehydration

Phase 1 management of hypernatremic dehydration is identical to that of isonatremic dehydration. Rapid volume expansion with 20 mL/kg of isotonic sodium chloride solution or lactated Ringer solution should be administered and repeated until perfusion is restored.

Varied regimens may be successfully followed to achieve correction of severe hypernatremia (>150 mEq/L). In phase 2 management, the most important goal is to reestablish intravascular volume if not done already in stage 1 and return serum sodium levels toward the reference range by not more than 10 mEq/L/24h. Rapid correction of hypernatremic dehydration can have disastrous neurologic consequences, including cerebral edema and death.

The most cautious approach is to plan a slow correction of the fluid deficit over 48 hours. Following adequate intravascular volume expansion, rehydration fluids should be initiated with 5% dextrose in 0.9% sodium chloride. Serum sodium levels should be assessed every 2-4 hours. If the sodium has decreased by less than 0.5 mEq/L/h, then the sodium content of the rehydration fluid is decreased. This allows for a slow controlled correction of the hypernatremic state.

Hyperglycemia and hypocalcemia are sometimes associated with hypernatremic dehydration. Serum glucose and calcium levels should be closely monitored.

Pharmacologic management

Note the following:

Diet

ORT may be continued at home if clear instructions are provided for the family and if the family members can be relied upon to carry out the hydration regimen. Close follow-up by the primary physician is recommended.

Children with dehydration from gastroenteritis have decreased duration of diarrhea when feedings are started as soon as the patient is able to tolerate oral intake.

Diluting milk or formula is not indicated. Breast-feeding should be resumed as soon as possible.

Foods that contain complex carbohydrates (eg, rice, wheat, potatoes, bread, cereals), lean meats, fruits, and vegetables are encouraged. Fatty foods and simple carbohydrates should be avoided.

Prevention

Consider rotavirus vaccination in infants, as rotavirus infection may cause diarrhea and/or vomiting, which can sometimes be severe enough to lead to dehydration.[25] Indeed, rotavirus infection is the principal cause of severe diarrhea in this population.[26] Infants who should not receive rotavirus vaccine include those who have (1) severe combined immunodeficiency (SCID), (2) immune deficiency from other causes (eg, HIV/AIDS, cancer, steroid therapy), and (3) a history of intussusception.[25]

In a study of hospitalizations for pediatric dehydration, Shanley et al found evidence that a large number of these hospitalizations were preventable. The study involved 85 children (mean age 1.6 y) who were diagnosed with dehydration, with a cross-sectional survey conducted of the children’s primary care physicians (PCP), inpatient attending physicians, and parents to determine factors contributing to their hospitalization. In 12% of cases, there was unanimous agreement between the PCP, attending physician, and parent that the hospitalization could have been prevented, while in 45% of cases at least one of these believed that the hospitalization was preventable.

Based on the survey, reasons that the preventable hospitalizations occurred included the following[27] :

Ondansetron (Zofran)

Clinical Context:  Selective 5-HT3-receptor antagonist that blocks serotonin both peripherally and centrally. Prevents nausea and vomiting associated with emetogenic cancer chemotherapy (eg, high-dose cisplatin), and complete body radiotherapy.

Class Summary

In an emergency department study, ondansetron was shown to decrease likelihood of vomiting, increase oral intake, and decrease emergency department length of stay.[22]

What is dehydration?What is the pathophysiology of dehydration?Which patient groups are at higher risk for dehydration?How is dehydration categorized?What are neurologic complications of dehydration?Why must the cause of dehydration be determined?What are common causes of dehydration?What are life threatening causes of dehydration?What is the prevalence of dehydration in the US?What is the global prevalence of dehydration?What is the prognosis of dehydration?What is the morbidity associated with dehydration?What should be the focus of clinical history during the evaluation of dehydration?Which physical findings are characteristic of dehydration?Which comorbidities must be diagnosed and treated in a patient with dehydration?What are the differential diagnoses for Dehydration?When are lab tests performed in the workup of dehydration?What is the role of lab testing in the workup of severe dehydration?How is an IV line inserted for the management of dehydration?What is the role of intraosseous cannulation in the management of dehydration?What is the role of orogastric or nasogastric tube placement in the management of dehydration?What are treatment options for dehydration?How are oral rehydration solutions used in the treatment of dehydration?How is oral rehydration therapy (ORT) administered for the treatment of dehydration?What is the medical treatment for severe dehydration?How are fluid requirements calculated for the treatment of severe dehydration?How is hyponatremic dehydration treated?How is hypernatremic dehydration treated?What is included in the pharmacologic management of dehydration?Which dietary modifications are required for the treatment of dehydration?How is dehydration prevented?Which medications in the drug class Antiemetic, Serotonin Antagonist are used in the treatment of Dehydration?

Author

Lennox H Huang, MD, FAAP, Chief Medical Officer, The Hospital for Sick Children; Associate Professor of Pediatrics, University of Toronto Faculty of Medicine; Associate Clinical Professor of Pediatrics, McMaster University School of Medicine, Canada

Disclosure: Nothing to disclose.

Coauthor(s)

Caroline S George, MD, Associate Professor, Consulting Staff, Department of Pediatrics, Division of Critical Care Medicine, University of Minnesota Medical School

Disclosure: Nothing to disclose.

Dan L Ellsbury, MD, Consulting Staff, Pediatrix Medical Group of Iowa; Consulting Staff, Department of Pediatrics, Neonatology Intensive Care Unit, Mercy Medical Center of Des Moines

Disclosure: Nothing to disclose.

Krishnapriya R Anchala, MD, MS, FAAP, Assistant Professor, Department of Pediatrics, Division of Pediatric Emergency Medicine, McMaster University School of Medicine, Canada

Disclosure: Nothing to disclose.

Specialty Editors

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Barry J Evans, MD, Assistant Professor of Pediatrics, Temple University Medical School; Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Timothy E Corden, MD, Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Disclosure: Nothing to disclose.

Additional Contributors

G Patricia Cantwell, MD, FCCM, Professor of Clinical Pediatrics, Chief, Division of Pediatric Critical Care Medicine, University of Miami Leonard M Miller School of Medicine/ Holtz Children's Hospital, Jackson Memorial Medical Center; Medical Director, Palliative Care Team, Holtz Children's Hospital; Medical Manager, FEMA, South Florida Urban Search and Rescue, Task Force 2

Disclosure: Nothing to disclose.

References

  1. Bettari L, Fiuzat M, Shaw LK, et al. Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. J Card Fail. 2012 Jan. 18(1):74-81. [View Abstract]
  2. Guarner J, Hochman J, Kurbatova E, Mullins R. Study of outcomes associated with hyponatremia and hypernatremia in children. Pediatr Dev Pathol. 2011 Mar-Apr. 14(2):117-23. [View Abstract]
  3. Zaki SA, Mondkar J, Shanbag P, Verma R. Hypernatremic dehydration due to lactation failure in an exclusively breastfed neonate. Saudi J Kidney Dis Transpl. 2012 Jan. 23(1):125-8. [View Abstract]
  4. Arora SK. Hypernatremic disorders in the intensive care unit. J Intensive Care Med. 2013 Jan-Feb. 28(1):37-45. [View Abstract]
  5. Colletti JE, Brown KM, Sharieff GQ, Barata IA, Ishimine P, ACEP Pediatric Emergency Medicine Committee. The management of children with gastroenteritis and dehydration in the emergency department. J Emerg Med. 2010 Jun. 38(5):686-98. [View Abstract]
  6. Parkin PC, Macarthur C, Khambalia A, Goldman RD, Friedman JN. Clinical and laboratory assessment of dehydration severity in children with acute gastroenteritis. Clin Pediatr (Phila). 2010 Mar. 49(3):235-9. [View Abstract]
  7. Koster C, Klingelhofer D, Groneberg DA, Schwarzer M. Rotavirus - Global research density equalizing mapping and gender analysis. Vaccine. 2016 Jan 2. 34(1):90-100. [View Abstract]
  8. Cheuvront SN, Kenefick RW, Montain SJ, Sawka MN. Mechanisms of aerobic performance impairment with heat stress and dehydration. J Appl Physiol. 2010 Dec. 109(6):1989-95. [View Abstract]
  9. [Guideline] Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics. 2008 Sep. 122(3):545-9. [View Abstract]
  10. Caruggi S, Rossi M, De Giacomo C, et al. Pediatric dehydration assessment at triage: prospective study on refilling time. Pediatr Gastroenterol Hepatol Nutr. 2018 Oct. 21 (4):278-88. [View Abstract]
  11. Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated?. JAMA. 2004 Jun 9. 291(22):2746-54. [View Abstract]
  12. Steiner MJ, Nager AL, Wang VJ. Urine specific gravity and other urinary indices: inaccurate tests for dehydration. Pediatr Emerg Care. 2007 May. 23(5):298-303. [View Abstract]
  13. Brandt KG, de Castro Antunes MM, da Silva GA. Acute diarrhea: evidence-based management. J Pediatr (Rio J). 2015 Nov-Dec. 91 (6 Suppl 1):S36-43. [View Abstract]
  14. [Guideline] Carson RA, Mudd SS, Madati PJ. Clinical practice guideline for the treatment of pediatric acute gastroenteritis in the outpatient setting. J Pediatr Health Care. 2016 Nov - Dec. 30(6):610-6. [View Abstract]
  15. Lee GO, Richard SA, Kang G, et al, for the MAL-ED Network Investigators. A comparison of diarrheal severity scores in the MAL-ED multisite community-based cohort study. J Pediatr Gastroenterol Nutr. 2016 Nov. 63(5):466-73. [View Abstract]
  16. World Health Organization. WHO Drug Information Vol. 16, No. 2, 2002: new formula oral rehydration salts. Available at http://apps.who.int/medicinedocs/en/d/Js4950e/2.4.html. May 10, 2002; Accessed: November 29, 2018.
  17. UNICEF. New formulation of oral rehydration salts (ORS) with reduced osmolarity - Report from a meeting of experts jointly organized by UNICEF and WHO. WHO/CAH/01.22. Technical bulletin no 9. May 10, 2002. Available at https://www.unicef.org/supply/files/Oral_Rehydration_Salts(ORS)_.pdf
  18. Kumar R, Kumar P, Aneja S, Kumar V, Rehan HS. Safety and efficacy of low-osmolarity ORS vs. modified rehydration solution for malnourished children for treatment of children with severe acute malnutrition and diarrhea: a randomized controlled trial. J Trop Pediatr. 2015 Dec. 61(6):435-41. [View Abstract]
  19. Atherly-John YC, Cunningham SJ, Crain EF. A randomized trial of oral vs intravenous rehydration in a pediatric emergency department. Arch Pediatr Adolesc Med. 2002 Dec. 156(12):1240-3. [View Abstract]
  20. Hartling L, Bellemare S, Wiebe N, Russell K, Klassen TP, Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. 2006 Jul 19. 3:CD004390. [View Abstract]
  21. Danewa AS, Shah D, Batra P, Bhattacharya SK, Gupta P. Oral ondansetron in management of dehydrating diarrhea with vomiting in children aged 3 months to 5 years: A Randomized Controlled Trial. J Pediatr. 2016 Feb. 169:105-9.e3. [View Abstract]
  22. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006 Apr 20. 354(16):1698-705. [View Abstract]
  23. Marchetti F, Bonati M, Maestro A, et al, for the SONDO (Study ONdansetron vs DOmperidone) Investigators. Oral ondansetron versus domperidone for acute gastroenteritis in pediatric emergency departments: multicenter double blind randomized controlled trial. PLoS One. 2016 Nov 23. 11(11):e0165441. [View Abstract]
  24. Uhlig U, Pfeil N, Gelbrich G, et al. Dimenhydrinate in children with infectious gastroenteritis: a prospective, RCT. Pediatrics. 2009 Oct. 124(4):e622-32. [View Abstract]
  25. Centers for Disease Control and Prevention. Rotavirus vaccine information statement (VIS). Updated: October 18, 2016. Available at http://www.cdc.gov/vaccines/hcp/vis/vis-statements/rotavirus.html. Updated: October 18, 2016; Accessed: November 27, 2016.
  26. Prasetyo D, Sabaroedin IM, Ermaya YS, Soenarto Y. Association between severe dehydration in rotavirus diarrhea and exclusive breastfeeding among infants at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. J Trop Med. 2015. 2015:862578. [View Abstract]
  27. Shanley L, Mittal V, Flores G. Preventing dehydration-related hospitalizations: a mixed-methods study of parents, inpatient attendings, and primary care physicians. Hosp Pediatr. 2013 Jul. 3(3):204-11. [View Abstract]
  28. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000 May 18. 342(20):1493-9. [View Abstract]
  29. Bellemare S, Hartling L, Wiebe N, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med. 2004 Apr 15. 2:11. [View Abstract]
  30. Bender BJ, Ozuah PO, Crain EF. Oral rehydration therapy: is anyone drinking?. Pediatr Emerg Care. 2007 Sep. 23(9):624-6. [View Abstract]
  31. Bhatnagar S, Bahl R, Sharma PK, et al. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial. J Pediatr Gastroenterol Nutr. 2004 Jan. 38(1):34-40. [View Abstract]
  32. Choice Study Group. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics. 2001 Apr. 107(4):613-8. [View Abstract]
  33. Dale J. Oral rehydration solutions in the management of acute gastroenteritis among children. J Pediatr Health Care. 2004 Jul-Aug. 18(4):211-2. [View Abstract]
  34. Duggan C, Fontaine O, Pierce NF, et al. Scientific rationale for a change in the composition of oral rehydration solution. JAMA. 2004 Jun 2. 291(21):2628-31. [View Abstract]
  35. Duggan C, Refat M, Hashem M, et al. How valid are clinical signs of dehydration in infants?. J Pediatr Gastroenterol Nutr. 1996 Jan. 22(1):56-61. [View Abstract]
  36. Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet. 2003 Oct 18. 362(9392):1320-3. [View Abstract]
  37. Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med. 2004 May. 158(5):483-90. [View Abstract]
  38. Gorelick MH, Shaw, KN, Murphy, KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics. 1997. May;(5):99:E6. [View Abstract]
  39. Holliday M. The evolution of therapy for dehydration: should deficit therapy still be taught?. Pediatrics. 1996 Aug. 98(2 Pt 1):171-7. [View Abstract]
  40. Holliday MA, Friedman AL, Segar WE, et al. Acute hospital-induced hyponatremia in children: a physiologic approach. J Pediatr. 2004 Nov. 145(5):584-7. [View Abstract]
  41. Holliday MA, Friedman AL, Wassner SJ. Extracellular fluid restoration in dehydration: a critique of rapid versus slow. Pediatr Nephrol. 1999 May. (4):292-7. [View Abstract]
  42. Hoorn EJ, Geary D, Robb M, et al. Acute hyponatremia related to intravenous fluid administration in hospitalized children: an observational study. Pediatrics. 2004 May. 113(5):1279-84. [View Abstract]
  43. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003 Nov 21. 52(RR-16):1-16. [View Abstract]
  44. Miyasaka K, Shimizu N, Kojima J. Recent trends in pediatric fluid therapy. Methods Find Exp Clin Pharmacol. 2004 May. 26(4):287-94. [View Abstract]
  45. Moritz ML, Ayus JC. Preventing neurological complications from dysnatremias in children. Pediatr Nephrol. 2005 Dec. 20(12):1687-700. [View Abstract]
  46. Moritz ML, Ayus JC. Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics. 2003 Feb. 111(2):227-30. [View Abstract]
  47. Moritz ML, Manole MD, Bogen DL, Ayus JC. Breastfeeding-associated hypernatremia: are we missing the diagnosis?. Pediatrics. 2005 Sep. 116(3):e343-7. [View Abstract]
  48. Murphy C, Hahn S, Volmink J. Reduced osmolarity oral rehydration solution for treating cholera. Cochrane Database Syst Rev. 2004. CD003754. [View Abstract]
  49. Nager AL, Wang VJ. Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration. Pediatrics. 2002 Apr. 109(4):566-72. [View Abstract]
  50. Nalin DR, Hirschhorn N, Greenough W, et al. Clinical concerns about reduced-osmolarity oral rehydration solution. JAMA. 2004 Jun 2. 291(21):2632-5. [View Abstract]
  51. Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics. 2002 Feb. 109(2):259-61. [View Abstract]
  52. Phin SJ, McCaskill ME, Browne GJ, Lam LT. Clinical pathway using rapid rehydration for children with gastroenteritis. J Paediatr Child Health. 2003 Jul. 39(5):343-8. [View Abstract]
  53. Playfor SD. Hypotonic intravenous solutions in children. Expert Opin Drug Saf. 2004 Jan. 3(1):67-73. [View Abstract]
  54. Reid SR, Bonadio WA. Outpatient rapid intravenous rehydration to correct dehydration and resolve vomiting in children with acute gastroenteritis. Ann Emerg Med. 1996 Sep. 28(3):318-23. [View Abstract]
  55. Santosham M, Keenan EM, Tulloch J, et al. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology. Pediatrics. 1997 Nov. 100(5):E10. [View Abstract]
  56. Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991. Jun;19(6):758-62. [View Abstract]
  57. Spandorfer PR, Alessandrini EA, Joffe MD, et al. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics. 2005 Feb. 115(2):295-301. [View Abstract]
  58. Wathen JE, MacKenzie T, Bothner JP. Usefulness of the serum electrolyte panel in the management of pediatric dehydration treated with intravenously administered fluids. Pediatrics. 2004 Nov. 114(5):1227-34. [View Abstract]
  59. Andrews JR, Leung DT, Ahmed S, et al. Determinants of severe dehydration from diarrheal disease at hospital presentation: Evidence from 22 years of admissions in Bangladesh. PLoS Negl Trop Dis. 2017 Apr. 11(4):e0005512. [View Abstract]
  60. Boskabadi H, Akhondian J, Afarideh M, et al. Long-term neurodevelopmental outcome of neonates with hypernatremic dehydration. Breastfeed Med. 2017 Apr. 12:163-8. [View Abstract]
Symptom/Sign Mild Dehydration Moderate Dehydration Severe Dehydration
Level of consciousnessAlertLethargicObtunded
Capillary refill*2 s2-4 s>4 s, cool limbs
Mucous membranesNormalDryParched, cracked
TearsNormalDecreasedAbsent
Heart rateSlightly increasedIncreasedVery increased
Respiratory rate/pattern*NormalIncreasedIncreased and hyperpnea
Blood pressureNormalNormal, but orthostasisDecreased
PulseNormalThreadyFaint or impalpable
Skin turgor*NormalSlowTenting
FontanelNormalDepressedSunken
EyesNormalSunkenVery sunken
Urine outputDecreasedOliguriaOliguria/anuria
* Best indicators of hydration status[11]
Severity Infants (weight < 10 kg) Children (weight >10 kg)
Mild dehydration5% or 50 mL/kg3% or 30 mL/kg
Moderate dehydration10% or 100 mL/kg6% or 60 mL/kg
Severe dehydration15% or 150 mL/kg9% or 90 mL/kg
Solution Carbohydrate (g/dL) Sodium (mEq/L) Potassium (mEq/L) Base (mEq/L) Osmolality
Pedialyte2.5452030250
Infalyte3502530200
Rehydralyte2.5752030310
Solution Sodium



(mEq/L)



Chloride



(mEq/L)



Glucose, Anhydrous



(mEq/L)



Potassium



(mEq/L)



Citrate



(mEq/L)



Osmolality
Standard90801112010311
Reduced osmolarity 7565752010245
UNICEF = United Nations International Children's Emergency Fund, WHO = World Health Organization.[16, 17]
Solution Carbohydrate (g/dL) Sodium (mEq/L) Potassium (mEq/L) Base (mEq/L) Osmolality
Apple juice120.4260700
Ginger ale93.50.13.6565
Milk4.9223630260
Chicken broth0233330